Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Somatostatin Receptor 2 ELISA Kit (AC2699)
Cat.#: ASET-1288
Specifications
Description Human Somatostatin Receptor 2 ELISA Kit allows for the in vitro quantitative determination of human Somatostatin Receptor 2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2228 Mouse Syndecan-1 ELISA Kit (AC3639) Quantitative inquiry ASET-2117 Human Sema6A ELISA Kit (AC3528) Quantitative inquiry ASET-1588 Human SOX2 ELISA Kit (AC2999) Quantitative inquiry ASET-1439 Human TORC2 ELISA Kit (AC2850) Quantitative inquiry ASET-1143 Mouse Insulin ELISA Kit (AC2554) Quantitative inquiry ASET-2065 Human FLJ39155 ELISA Kit (AC3476) Quantitative inquiry ASET-1983 Mouse SRD5A1 ELISA Kit (AC3394) Quantitative inquiry ASET-1185 Human NMDAR2A ELISA Kit (AC2596) Quantitative inquiry ASET-1735 Human NELL1 ELISA Kit (AC3146) Quantitative inquiry ASET-1176 Human CD97 ELISA Kit (AC2587) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket